Morroniside improves the symptoms of post-stroke depression in mice through the BDNF signaling pathway mediated by miR-409-3p
Lihui Qian,Sirui Huang,Xiaoli Liu,Yongxia Jiang,Yongqu Jiang,Yue Hu,Zhou Yang
DOI: https://doi.org/10.1016/j.phymed.2023.155224
IF: 6.656
2023-11-18
Phytomedicine
Abstract:Background : Post-stroke depression (PSD) is a common psychiatric symptom after stroke. Morroniside, an iridoid glycoside found in Cornus officinalis , has garnered significant attention for its potential in alleviating symptoms associated with depression. Purpose : This study aims to highlight the potential use of morroniside in the treatment of PSD and elucidate the underlying molecular mechanisms. Methods : To establish a reliable PSD model, male C57BL/6 mice were subjected to brief MCAO in conjunction with CUMS. Post-morroniside administration, neuronal viability, and hippocampal cell apoptosis were evaluated by Nissl staining and TUNEL detection, respectively. Depression-like behaviors were evaluated using SPT, TST, and FST. The Longa score and cylinder test were used to evaluate the effect of morroniside on motor function. Furthermore, to investigate the underlying molecular mechanisms, bioinformatic analysis, dual luciferase assay was performed to investigate for miR-409-3p-BDNF interaction. In addition, subsequent to miR-409-3p overexpression via AAV virus, we assessed mRNA expression and protein levels of key components within the BDNF/TrkB signaling pathway using RT-qPCR, immunohistochemistry, and western blot analysis. Results : The observed decrease in apoptosis and amelioration of depression-like behaviors strongly indicate the potential of morroniside as a therapeutic agent for PSD. Furthermore, the upregulation of key proteins within the BDNF/TrkB signaling pathway in the cortex suggests that morroniside activates this pathway. Through bioinformatics analysis, miR-409-3p was identified and found to bind to the BDNF gene, resulting in the inhibition of BDNF expression. Importantly, we demonstrate that morroniside mitigates this inhibitory effect of miR-409-3p on BDNF, thereby facilitating the activation of the BDNF/TrkB signaling pathway. Conclusion : The findings suggest that morroniside demonstrates the ability to improve PSD symptoms through the BDNF/TrkB signaling pathway mediated by miR-409-3p. These results emphasize the importance of the BDNF signaling pathway in improving PSD symptoms and provide a possible mechanism for morroniside to treat PSD.
pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences